Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of PTK787/ZK222584 in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Who Failed First-Line Gemcitabine Therapy.

NCT00226005 is registered in ClinicalTrials.gov with Pancreatic Cancer Research Team as lead sponsor.

NCT NCT00226005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of PTK787/ZK222584 in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Who Failed First-Line Gemcitabine Therapy.
Lead sponsor
Pancreatic Cancer Research Team
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
February 28, 2010
Enrollment
67 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm